InvestorsHub Logo
Followers 0
Posts 1586
Boards Moderated 1
Alias Born 06/25/2019

Re: NobleRoman post# 27

Tuesday, 04/20/2021 6:58:43 PM

Tuesday, April 20, 2021 6:58:43 PM

Post# of 70
$9 remains elusive. KERN drops a buck and FORA goes up a buck. This must be let's-harass-NobleRoman week.

So basically, as others noted, HLIX did a reverse split and applied for Nasdaq listing and got it. But it's more complicated. HLIX had assets, and somebody merged into them.

Curiously, there is a similar story unfolding on a shell called STLY in my eyes. It was formerly Stanley Furniture. It's not an empty shell though. It's a shell company with lots of cash and interest-bearing assets, producing net profits from interest alone. Low share count. They just filed for a reverse split. It may be 1 for 10 or as high as 1 for 25. And then they are going to apply for Nasdaq.

It's hard to get shares there. I bought 10,000 shares at an avg. price of .62. I want to see how it plays out. My expectation is that some company will reverse merge into it as well, eventually. So if it goes Nasdaq, I would view that as similar to a SPAC in my eyes. It would have a low float. But unlike here, it would be a mysterious suitor in the future. And I love mystery gifts.

An interesting case for it is here at Seeking Alpha:

https://seekingalpha.com/article/4233584-hg-holdings-this-50-cent-stock-1-in-assets-and-potential-game-changing-catalyst

Just noting some parallels is all. I like the alignment of interests over there. There was a capital raise at .65 per share last year. Something's going on, and it has credible people and hard evidence of great assets in its filings. Check it out.

But don't drive the price up. If you want in, don't get in hire than me. Try to get in lower. Just for greed purposes only. And only if you have patience. Patience is a virtue!

I just want to get in FORA. It's the only thing I want that I don't have so far.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent FORA News